Allarity Therapeutics Inc (ALLR): Definitely shenanigans If the RS short...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	133
Posts	23049
Boards Moderated	0
Alias Born	05/15/2009

just Scottie

Re: eyeownu post# 391

Tuesday, 06/25/2024 5:31:59 PM

Tuesday, June 25, 2024 5:31:59 PM

Definitely shenanigans
If the RS shorts will attack and bring it down again
They need an alternative. Partnerships joint venture or buyout

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ALLR News

Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 12:54:39 PM
Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress • GlobeNewswire Inc. • 03/31/2026 12:00:00 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:29:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 01:02:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 01:22:50 PM
Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization • GlobeNewswire Inc. • 03/06/2026 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 01:00:48 PM
Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need • GlobeNewswire Inc. • 02/18/2026 01:15:00 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/12/2026 09:18:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 01:00:35 PM
Allarity Therapeutics announces that its collaborative Phase 2 trial with the United States Veteran’s Administration Combining Stenoparib with Temozolomide in Relapsed Small Cell Lung Cancer is Now Open for Enrollment • GlobeNewswire Inc. • 02/03/2026 01:00:00 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/29/2026 01:00:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2026 12:49:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 09:13:58 PM
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders • GlobeNewswire Inc. • 12/31/2025 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 02:21:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2025 02:16:37 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/08/2025 05:15:20 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/03/2025 02:11:40 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 02:00:59 PM
Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/14/2025 02:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2025 08:05:10 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/30/2025 09:17:29 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/25/2025 09:19:46 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent ALLR News

More ALLR News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ALLR News

Go Ad-Free